Skip to content

Medical-device intelligence

NQX: System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

FDA product code NQX: System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NQX
FDA device name
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

FDA definition

A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of MRSA colonization status for the prevention and control of MRSA infections in healthcare settings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

24 clearance records and 20 recall records in the covered releases, across 14 source company names and 1 product codes. Dated history runs from Mar 18, 2004 to Aug 6, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

44 matching records
Device / recordCompany in FDA recordSourceSource date
BD MAX DNA Extraction Kit DNA-3 (Swabs in Transport Medium/UTM), Catalog Number 437503. Kit contains 24/2D barcode sample preparation reagent tu…Z-3218-2011 · NQXBecton Dickinson & Co.RecallSep 16, 2011FDA classification date
BD MAX RNA Extraction Kit RNA-3, Catalog Number 437506. Kit contains 24/2D barcode sample preparation reagent tubes. The BD MAX RNA Extraction K…Z-3219-2011 · NQXBecton Dickinson & Co.RecallSep 16, 2011FDA classification date
BD MAX GBS Catalog Number 441772 For In Vitro Diagnostic Use, For use with the BD MAX system.The Sample Preparation Reagent kit consists of 24 (2…Z-3220-2011 · NQXBecton Dickinson & Co.RecallSep 16, 2011FDA classification date
NUCLISENS EASYQ MRSA; NUCLISENS EASYQ ANALYZER; NUCLISENS EASYQ INCUBATOR (110 VOLT); NUCLISENS DIRECTOR V.2.6K102740 · NQXbioMerieux, Inc.510(k)May 20, 2011FDA decision date
XPERT MRSA/SA BC (BLOOD CULTURE) ASSAY MODEL GXMRSA/SA-BC-10K101879 · NQXCepheid510(k)Jul 28, 2010FDA decision date
LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENT, MODEL 05205727K091409 · NQXRoche Molecular Systems, Inc.510(k)Jul 6, 2010FDA decision date
Cepheid Xpert MRSA/SA Blood Culture Test for use with the GeneXpert Dx System, manufactured by Cepheid, Sunnyvale, CA. Medical device, qualitat…Z-1898-2010 · NQXCepheidRecallJul 1, 2010FDA classification date
XPERT MRSA/SA NASAL ASSAYK100822 · NQXCepheid510(k)Jun 1, 2010FDA decision date
BD GENEOHM MRSA ACP ASSAYK093346 · NQXBd Diagnostics (Geneohm Sciences, Inc.)510(k)Dec 15, 2009FDA decision date
BD Diagnostics, BD GeneOhm MRSA Assay, REF: 441242 (200 Reaction Kit) and 441244 (48 Reaction Kit). For the rapid detection of methicillin resis…Z-1963-2009 · NQXBD Diagnostics (GeneOhm Sciences, Inc)RecallSep 10, 2009FDA classification date
BD GeneOhm MRSA 200 ct, Catalog #441242. IDI-MRSA assay is a qualitative in vitro diagnostic test for the direct detection of nasal colonizatio…Z-0225-2009 · NQXBD Diagnostics (GeneOhm Sciences, Inc)RecallOct 31, 2008FDA classification date
BD GeneOhm MRSA 48 ct, Catalog #441244. IDI-MRSA assay is a qualitative in vitro diagnostic test for the direct detection of nasal colonization …Z-0226-2009 · NQXBD Diagnostics (GeneOhm Sciences, Inc)RecallOct 31, 2008FDA classification date
XPERT MRSA/SA BLOOD CULTURE ASSAYK082140 · NQXCepheid510(k)Sep 29, 2008FDA decision date
XPERT MRSA/SA SSTI ASSAYK080837 · NQXCepheid510(k)Sep 24, 2008FDA decision date
BD GENEOHM STAPHSR ASSAYK071026 · NQXBd Diagnostics (Geneohm Sciences Canada, Inc)510(k)Dec 20, 2007FDA decision date
XPERT MRSAK070462 · NQXCepheid510(k)Apr 17, 2007FDA decision date
Doc-U-Dose Prescription Management System, Item 8-PKIT. The product is packaged and distributed in cartons. Each carton contains 1,000 sets of …Z-0189-2007 · NQXEatonform IncRecallNov 16, 2006FDA classification date
IDI-MRSA ASSAYK042357 · NQXInfectio Diagnostic (I.D.I.), Inc.510(k)Oct 22, 2004FDA decision date
IDI-MRSAK033415 · NQXInfectio Diagnostic (I.D.I.), Inc.510(k)Mar 18, 2004FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗